Amber D. Bowler - Concepedia

Author

Amber D. Bowler

Huntsman Cancer Institute ORCID

Also Known As

A Bowler, A D Bowler, Amber D Bowler, Amber D. Bowler, Ann Bowler

Publications

643

Citations

H-Index

Concepts

All Affiliations

Huntsman Cancer Institute University of Utah École Polytechnique Fédérale de Lausanne Oregon Health & Science University Tsinghua University

About

Amber D. Bowler is an author at Huntsman Cancer Institute specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	317
2	Cell Biology	2	2	61
3	Immunology	2	2	258
4	Nursing	1	1	17
5	Social Sciences	1	1	17

Amber D. Bowler

Publications

635

Citations

H-Index

Page 1

	Year	Citations
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants Christopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage, Cancer Cell Allosteric Inhibitor AsciminibMedicineImmunologyPharmacotherapyPonatinib Suppresses Emergence	2019	239
Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of <scp>TGF</scp> β Markus Germann, Nadine Zangger, Marc‐Olivier Sauvain, EMBO Molecular Medicine	2019	161
Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo L. Francisco Lorenzo‐Martín, Tania Hübscher, Amber D. Bowler, Nature	2024	81
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance Jamshid S. Khorashad, Anna M. Eiring, Clinton C. Mason, Blood	2015	44
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia Anna M. Eiring, Jamshid S. Khorashad, David Anderson, Leukemia Hematological MalignancyChronic Myeloid LeukemiaMedicinePharmacologyKinase Inhibitors	2015	42
Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth Anita Bodac, Abdullah Mayet, Sarika Rana, EMBO Molecular Medicine	2023	32
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis Helong Zhao, Anthony D. Pomicter, Anna M. Eiring, Blood Hematological MalignancyTranscriptional RegulationChronic Myeloid LeukemiaCell RegulationImmune Cell Development	2021	19
Association between psychological distress and cancer type in patients referred to a psycho-oncology service. Clianna Lavelle, Muhammad Ismail, Kieran Doherty, PubMed Psychological Co-morbiditiesPsycho-oncology ServiceCancer ManagementCancer RegistrationMental Health	2017	17

Page 1